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The distribution, spread, neuropathology, tropism, and persistence of the neurovirulent GDVII strain of
Theiler’s virus in the central nervous system (CNS) was investigated in mice susceptible and resistant to
chronic demyelinating infection with TO strains. Following intracerebral inoculation, the virus spread rapidly
to specific areas of the CNS. There were, however, specific structures in which infection was consistently
undetectable. Virus spread both between adjacent cell bodies and along neuronal pathways. The distribution
of the infection was dependent on the site of inoculation. The majority of viral RNA-positive cells were neurons.
Many astrocytes were also positive. Infection of both of these cell types was lytic. In contrast, viral RNA-positive
oligodendrocytes were rare and were observed only in well-established areas of infection. The majority of
oligodendrocytes in these areas were viral RNA negative and were often the major cell type remaining; however,
occasional destruction of these cells was observed. No differences in any of the above parameters were observed
between CBA and BALB/c mice, susceptible and resistant, respectively, to chronic CNS demyelinating infection
with TO strains of Theiler’s virus. By using Southern blot hybridization to detect reverse-transcribed PCR-
amplified viral RNA sequences, no virus persistence could be detected in the CNS of immunized mice surviving
infection with GDVII. In conclusion, the GDVII strain of Theiler’s murine encephalomyelitis virus cannot
persist in the CNS, but this is not consequent upon an inability to infect glial cells, including oligodendrocytes.
Theiler’s murine encephalomyelitis virus (TMEV), a natu-
rally occurring enteric pathogen of mice, is a picornavirus
belonging to the Cardiovirus genus (30, 32, 36). Two subgroups
are recognized on the basis of neurovirulence after intracere-
bral (i.c.) inoculation (25). One subgroup consists of TO (Thei-
ler’s original) virus strains which after i.c. inoculation, depend-
ing on the mouse strain, cause a persistent demyelinating
infection of the central nervous system (CNS) in a proportion
of mice that survive acute infection (21, 25, 47). Examples of
TO virus strains are BeAn, DA, and WW. Mouse strains ex-
hibit differential susceptibility to this chronic infection; SJL/J
and PL/J mice are highly susceptible, and BALB/c and
C57BL/6 mice are resistant. CBA mice show intermediate sus-
ceptibility. During persistent chronic infection, TO virus
strains infect glial cells and give rise to lesions of demyelination
(1, 3, 9, 10, 25, 39, 44). The GDVII and FA strains, the second
subgroup, are highly neurovirulent and produce a fulminant
encephalomyelitis in mice of all genetic backgrounds. Clini-
cally, the mice exhibit circling behavior, breathing difficulties,
ruffled fur, and flaccid paralysis culminating in death (31, 48).
During CNS infection, GDVII replicates in neurons, leading
to widespread necrosis and extensive mononuclear cell inflam-
matory infiltrates (27, 44). GDVII has never been demon-
strated in white matter, and in vivo infection of glial cells has
not been studied. An intriguing question is whether GDVII
infects glial cells and can produce a persistent infection. Infec-
tivity studies of mice given sublethal doses of GDVII have
failed to convincingly demonstrate any viral persistence in the
CNS (26). Studies of recombinant GDVII and TO viruses have
sought to map phenotypic properties of TMEV to genetic loci.
Elucidation of the genetic determinants of neurovirulence,
persistence, and demyelination has proved difficult and con-
troversial (17, 18, 20, 24, 41, 46). Persistence is likely to be
governed by a variety of factors including viral tropism and
immune responses. In vitro, GDVII has been shown to infect
and cause demyelination in organotypic CNS cultures (42) and
to lytically infect cells in mixed glial cell cultures and cultures
of Schwann cells (16, 29). However, the in vivo tropism of
GDVII has not been subjected to detailed study. In this study,
we have investigated the distribution, spread, neuropathology,
and tropism of GDVII following infection of CBA and
BALB/c mice. The ability of GDVII to establish a persistent
infection of the CNS in CBA mice was also investigated.
MATERIALS AND METHODS
Viruses and animals. The GDVII strain of TMEV was a gift from H. Lipton
(Mount Sinai Medical Center, New York, N.Y.). Virus was grown in BHK-21
cells cultured in Glasgow’s modified Eagle’s medium (GMEM) supplemented
with 10% newborn calf serum and tryptose phosphate broth. Culture superna-
tants containing infectious virus were aliquoted and stored at 2708C. Four- to
6-week-old CBA and BALB/c mice were obtained from the Department of
Pathology Animal Unit (Cambridge University, Cambridge, United Kingdom)
and Olac (Bicester, United Kingdom). Mice were anesthetized, and 104 PFU of
virus in 20 ml of phosphate-buffered saline (PBS) was inoculated i.c. in the region
of the limbic or occipital cortex, close to the midline. Mice were euthanized at
various times, and CNS tissues were removed. The brains were divided sagittally,
and the spinal cords were divided laterally or longitudinally. The brain and cord
halves were either processed for RNA extraction, frozen for virus titration, or
fixed in 10% phosphate-buffered formalin for histological studies. Fixed tissues
were dehydrated and embedded in paraffin. The brains were cut sagittally close
to the midline, and the spinal cords were cross-sectioned in seven different areas.
Sections, 5 mm thick, were mounted on poly-L-lysine- or Biobond (British Bio-
cell)-coated slides.
Virus titers. Infectious virus was quantified by plaque assay on BHK-21 cell
monolayers. CNS tissues were weighed and homogenized, 1:5 and 1:10 (wt/vol)
for brains and spinal cords, respectively, in GMEM with 20 mM HEPES (N-2-
hydroxyethylpiperazine-N9-2-ethanesulfonic acid) buffer. Tenfold dilutions of
homogenized tissues or supernatant aliquots from mixed glial cell cultures were
added to PBS-washed cell monolayers and incubated for 45 min at room tem-
perature. Monolayers were then overlaid with 1% agar in GMEM supplemented
with 10% bovine serum albumin (BSA), incubated for 3 days at 378C, fixed in
10% formalin, and stained with toluidine blue, and the plaques were enumer-
ated. Virus titers were expressed as PFU per gram of CNS tissue or PFU per
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milliliter of culture supernatant. The limits of detection of the plaque assay were
101.7 and 102 PFU/g for brain and spinal cord tissues, respectively.
Peripheral immunization with heat-inactivated GDVII. GDVII was heat in-
activated at 658C for 1 h, after which no infectivity remained as determined by
plaque assay. CBA mice (3 to 4 weeks old) were primed with complete Freund’s
adjuvant containing heat-inactivated GDVII (2:1); each mouse received 106 to
107 PFU in 100 ml subcutaneously in the base of the tail. After 2 weeks, the mice
were boosted with incomplete Freund’s adjuvant–heat-inactivated GDVII (2:1)
subcutaneously in the flank.
In situ hybridization. Riboprobes were transcribed from a recombinant
pGEM 3 vector into which we had subcloned the 3.4-kb, SalI-XbaI restriction
fragment of the cDNA of the BeAn strain of TMEV, corresponding to nucle-
otides 1729 to 4733 on the BeAn infectious clone (35). Riboprobes were labelled
either with 35S-ATP and 35S-CTP or with digoxigenin-UTP. In situ hybridization
was performed as previously described (43). Briefly, after permeabilization, pre-
hybridization was performed at 558C for 1 h in a mixture of 50% deionized
formamide, 53 Denhardt’s solution, 0.1% sodium dodecyl sulfate, 0.75 M NaCl,
0.025 M PIPES [piperazine-N-N9-bis(2-ethanesulfonic acid)], 0.025 M EDTA,
500 mg of sonicated salmon sperm DNA per ml, 250 mg of yeast tRNA per ml and
20 U of heparin per ml. Hybridization in the same solution with the addition of
10% dextran sulfate was performed overnight at 558C. Stringency washes with
23 SSC (13 SSC is 0.15 M NaCl plus 0.015 M sodium citrate) and 0.23 SSC
were carried out for 15 min at 37 and 558C, respectively. For 35S-labelled
riboprobes, sections were dehydrated, air dried, and exposed to high-resolution
b-max film (Amersham, Amersham, United Kingdom) before being dipped in
photographic emulsion. The length of exposure was from 4 to 7 days, as appro-
priate. Finally, slides were developed and conterstained with hematoxylin and
eosin. For digoxigenin-labelled riboprobes, slides were incubated with sheep
anti-digoxigenin immunoglobulin G conjugated to alkaline phosphatase (Boehr-
inger Mannheim), and the reaction was visualized by using nitroblue tetrazolium
and X-phosphate to give a blue product. Alternatively, digoxigenin probes were
visualized by using an avidin-biotin-peroxidase kit, with sheep anti-digoxigenin
immunoglobulin G and biotinylated goat anti-sheep immunoglobulin G and
diaminobenzidine as the substrate, giving a brown reaction product.
Immunostaining and double labelling. Immunostaining of paraffin-embedded
sections was performed as described previously (44). Briefly, sections were
deparaffinized; treated with 0.3% hydrogen peroxide; rehydrated; incubated for
2 h at room temperature with a primary antibody, either rabbit polyclonal
anti-bovine glial fibrillary acidic protein (GFAP) (Dakopatt) or rabbit polyclonal
anti-bovine 29,39-cyclic-nucleotide-39-phosphohydrolase (CNPase) (a kind gift
from F. A. McMorris [38]); and then incubated for 1 h at room temperature with
a secondary biotinylated goat anti-rabbit IgG (Vector Laboratories). The signal
was amplified by using a Vector Laboratories ABC kit according to the manu-
facturer’s instructions, and virus-positive cells were visualized by using diamino-
benzidine as the substrate. For double-labelling in situ hybridization for viral
RNA, the use of a 35S-labelled riboprobe was followed by immunostaining for
phenotypic markers. After dehydration of the sections following the final SSC
washes in the in situ hybridization procedure, the sections were immunostained,
starting with 0.3% hydrogen peroxide. After immunostaining, the slides were
dipped in photographic emulsion and counterstained as described above.
RNA preparation. Total RNA was extracted from the brain and spinal cord
tissues of infected mice and infected BHK monolayers by the guanidine thiocy-
anate method as described previously (29). GDVII RNA was prepared from
purified virus as described previously (8, 44). The concentration of RNA was
calculated from the A260 value and used to standardize the reverse transcription
(RT)-PCR.
RT-PCR.RT-PCR was performed by using a GeneAmp thermostable rTth RT
RNA PCR kit (Perkin-Elmer Cetus) as previously described (44). Briefly, RT
was performed with 100 ng of total CNS (brain and spinal cord) RNA with a
23-mer oligonucleotide primer complementary to nucleotides 3883 to 4005 of the
GDVII strain of TMEV (35). After first-strand cDNA synthesis, a 17-mer up-
stream primer corresponding to nucleotides 3081 to 3098 of the GDVII strain of
TMEV (35) was added, and the reaction mixture was subjected to 35 cycles of
amplification (94 and 558C for 20 s each, followed by 608C for 60 s) in a Techne
PHC-3 thermal cycler. The PCR products (1/10 of the reaction mix) were added
to a 1% agarose gel and analyzed by Southern blot with digoxigenin probes
detected by enhanced chemiluminescence (44).
RESULTS
Clinical disease and CNS virus titers. The course of virus
replication in the CNS was determined for GDVII in both
CBA and BALB/c mice. Three animals of each strain were
sampled at days 1, 2, 3, 4 and 5 postinfection. The animals
started to die at 3 days, with signs of acute encephalomyelitis,
which included circling behavior, dyspnea, ruffled fur, and flac-
cid paralysis. All mice were dead by 5 days postinfection. In-
fectivity titers (Fig. 1) were equivalent in CBA and BALB/c
mice. Virus titers in the brain increased rapidly and steadily,
reaching maximum values within 3 days of infection. Virus
titers in the spinal cord increased with time but showed more
variability than those in the brain.
CNS virus distribution and spread. The temporal course of
GDVII RNA distribution in the CNS of CBA and BALB/c
mice was determined. Three adjacent sections from each of
two animals from each strain at each time point were studied
by in situ hybridization and autoradiographic analysis. The
same sections were then dipped in photographic emulsion and
examined microscopically. The specificity of the riboprobe was
tested on age-matched, noninfected and Semliki Forest virus-
infected mouse CNS tissues (14). No positive signal was de-
tected in any of the control tissues. Representative autoradio-
graphic images are shown in Fig. 2. There was no difference in
the distributions of GDVII RNA in CBA and BALB/c mice.
Virus was first apparent as small foci at 1 day postinfection and
spread rapidly from these sites. By the time of death, a con-
sistent pattern of infection, which included the cerebral cortex
(predominantly the deep layers), pyramidal neurons of the
hippocampus, basal ganglia, hypothalamus, substantia nigra,
pons, and spinal cord grey matter, was established. No virus-
positive cells were detected in the corpus callosum, cerebel-
lum, dentate gyrus, or molecular layer of the hippocampus,
which were consistently negative for virus even when surround-
ing cells were positive (Fig. 2 and 3). The spread of infection to
outer cortical layers, inferior and superior colliculi, central
thalamic nuclei, and the brain stem was rare.
The rapid spread of infection, adjacent virus-positive cell
bodies, and the presence of viral genomes in neuronal pro-
cesses and in certain connected nuclei indicate rapid cell-to-
FIG. 1. Brain (A) and spinal cord (B) virus titers from CBA (closed trian-
gles) and BALB/c (open circles) mice inoculated i.c. with 104 PFU of GDVII.
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cell spread between both adjacent and distant but connected
cells. Cortical neurons in layers IV, V, and VI were frequently
infected. Layer V neurons project to the superior colliculus,
basal ganglia, hypothalamus, and spinal cord via the internal
capsule, while layers IV and VI neurons project to thalamic
nuclei. That the basal ganglia, hypothalamus, spinal cord, and
dentate gyrus were infected but not the superior colliculus or
hippocampal pyramidal neurons suggests either that virus can-
not disseminate along certain pathways or that subpopulations
of neurons differ in their ability to be infected or to sustain
virus replication or both. To investigate whether the consistent
absence of viral RNA in specific structures represented an
inability to reach, infect, or replicate within these areas, 104
PFU of GDVII virus was inoculated directly into the cerebella
of CBA mice. Histological examination at 2 and 4 days posti-
noculation demonstrated destructive infection of granule and
Purkinje cells (Fig. 3B), with spread of infection to the areas
described above.
One striking feature of the autoradiographic analysis of the
distribution of viral RNA-positive cells in the brains and spinal
cords was the rarity of signal over white matter tracts such as
the corpus callosum, internal capsule, and cerebellar peduncle
(Fig. 3). These were consistently virus negative on autoradio-
graphic images despite widespread infection in adjacent tissue
(Fig. 2 and 3). A similar picture was observed following the
exposure of sections to photographic emulsion for 7 days and
microscopic examination. At boundaries between white and
grey matter, for example, at the junction of cortex and corpus
callosum, many virus-positive cells in the grey matter were
surrounded by the strong precipitation of silver grains while
FIG. 2. Representative autoradiographic images showing temporal changes in GDVII RNA distribution in CNS of mice. In situ hybridization on sagittal and
transverse sections of brain and spinal cord, respectively, with a 35S-labelled riboprobe complementary to the viral genomic RNA. Note the absence of signals in the
corpus callosum (cc), cerebellum (cb), central thalamic nuclei (t), inferior and superior colliculi (isc), and outer layers of the neocortex (c).
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FIG. 3. Representative photomicrographs illustrating the histopathology and tropism of GDVII infection in the CNS of CBA and BALB/c mice at 3 or 4 days
postinfection. All sections were 5 mm from paraffin-embedded material. GDVII RNA-positive cells were detected by in situ hybridization with a riboprobe labelled with
35S or digoxigenin and visualized, respectively, by exposure to photographic emulsion (E to J, L, M, and Q) or by antibody detection using nitroblue tetrazolium and
X-phosphate (A) or diaminobenzidine to give a brown reaction product (B, C, D, K, O, and P). 35S in situ hybridization for viral RNA was followed by immunostaining
for cell phenotypic markers with antibodies to CNPase for oligodendrocytes (E to J) and to GFAP for astrocytes (L and M). (A) GDVII RNA-positive cells with typical
neuronal morphology in cerebral cortex. Staining is exclusively cytoplasmic with viral RNA present in cell processes (arrowhead). (B) Destructive infection of granule
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cells in the adjacent white matter were virus negative. How-
ever, in the white matter of some mice, isolated, scattered,
single virus-positive cells were occasionally observed (Fig. 3Q).
Histopathology and viral tropism. The gross appearance of
the brain and spinal cord tissues in moribund mice was watery
and soft. At days 1 and 2 postinfection, submeningeal and
perivascular inflammatory infiltrates consisting of mononu-
clear and polymorphonuclear cells were observed. Viral infec-
tion was usually limited to the vicinity of the needle track. On
days 3 to 5 postinfection, an acute viral encephalomyelitis with
infiltrating mononuclear cells was observed. Meningitis was
mild. Mononuclear perivascular inflammatory exudates were
extensive, and in some mice scattered polymorphonuclear cells
were present (Fig. 3R). With time, increasing numbers of cells
in the areas of infection showed degenerative changes or had
undergone cell death (Fig. 3D, H, J, M, and P). Degenerative
changes included smaller sizes, abnormal shapes, and more-
intense staining of the cytoplasm and nucleus. Pycnotic and
karyorhexic nuclei were present (Fig. 3D, H, and P). Areas of
extensive cell death were characterized by chromatolysis,
mononuclear inflammation, and, in some cases, vacuolation of
the neuropil. In areas of infection, GFAP staining demon-
strated astrocytosis and astrocyte hypertrophy. Microglial pro-
liferation was present as evidenced by cells with small baso-
philic, rod-shaped nuclei and occasional neuronophagia (Fig.
3K).
Some GDVII RNA-positive or GDVII protein-positive cells
could be clearly identified as neurons, including motor neurons
in the spinal cord and pyramidal neurons of the hippocampus
(Fig. 3C, D, and O). In addition, infected cells with a distinct
neuronal morphology were observed throughout the CNS (Fig.
3A). Consistent with the known site of replication of this RNA
virus, viral RNA was detected in the cytoplasm but never in the
nucleus (Fig. 3A). Many virus-positive neurons showed degen-
erative changes or cell death. For example, by day 3 or 4
postinfection, pycnotic and karyorhexic nuclei associated with
staining for viral RNA or protein were consistently observed
throughout the pyramidal layer of the hippocampus (Fig. 3D).
In contrast, in all 30 mice studied which were inoculated in the
cortex, neurons in the dentate gyri and cerebella were never
positive for virus, neither RNA nor protein, and showed no
changes in morphology. Direct inoculation of virus into the
cerebellum resulted in infection and cell destruction (Fig. 3B).
GDVII infection of astrocytes and oligodendrocytes was de-
termined by 35S in situ hybridization for viral RNA followed by
immunostaining for GFAP or CNPase, phenotypic markers,
respectively, of astrocytes and oligodendrocytes. To check the
fidelity of the double-labelling technique, adjacent sections
were labelled by in situ hybridization only or immunostaining
only. The distributions of the in situ hybridization signal and
the immunostaining were identical in single- and double-la-
belled sections.
GDVII RNA-positive GFAP1 cells were detected in the
brains and spinal cords of both CBA and BALB/c mice. Only
a small proportion of the GDVII-positive cells were GFAP1.
GDVII-positive GFAP1 cells with an astrocytic morphology
were rare (Fig. 3L). Most double-labelled cells were rounded
and did not show typical astrocytic cell processes (Fig. 3M).
Infection of astrocytes was lytic, as evidenced by GFAP stain-
ing associated with nuclear debris and the absence of morpho-
logically normal astrocytes in areas of widespread infection and
cell destruction.
GDVII-positive CNPase1 cells were rare. In areas of limited
infection, as evidenced by no extensive cell death and few
virus-positive cells with a low density of silver grains, GDVII-
positive CNPase1 cells were never observed (Fig. 3E). In these
areas, even satellite oligodendrocytes adjacent to infected neu-
rons were consistently virus negative. In areas of extensive
infection, with many GDVII-positive cells with a high density
of silver grains and widespread cell death, the majority of intact
cells remaining could be clearly identified as CNPase1 but
were GDVII negative and had the morphological appearance
of normal oligodendrocytes (Fig. 3G and H). In these same
regions, GDVII-positive CNPase1 cells with a typical oligo-
dendrocyte morphology were rare and CNPase staining in as-
sociation with nuclear debris was rarely observed (Fig. 3J and
I). At no time postinfection were isolated single GDVII-posi-
tive CNPase1 cells observed in any part of the CNS.
In situ hybridization signals were never associated with the
rod-shaped nuclei characteristic of microglia, even when these
cells were adjacent to GDVII-positive cells (Fig. 3K). Attempts
to double-label these cells were unsuccessful, even in cryostat
sections. Viral RNA and viral protein were never observed in
meningeal, ependymal, cerebral endothelial, or choroid plexus
cells. In the many sections studied from brains and spinal cords
of both CBA and BALB/c mice at days 1 to 5 postinfection, no
differences in viral tropism were observed between these
mouse strains.
Virus persistence in vivo. To investigate the protective role
of the immune system and to determine whether GDVII virus
can persist in the CNS, CBA mice were peripherally immu-
nized with heat-inactivated GDVII and 2 weeks later chal-
lenged i.c. with GDVII virus. By this time the mice were 8 to
9 weeks old. It was assumed that the chance of establishing a
persistent infection would be greatest in mice given a maximal
but sublethal i.c. inoculation. In a pilot study of immunized
mice, this dose was found to be 100 PFU. Three naive CBA
mice and three sham-immunized mice were inoculated with
102 PFU of GDVII at 8 to 9 weeks of age. All six mice were
dead by day 10 postinoculation. In the experimental group of
45 immunized and infected mice, 10 were sampled on day 7. Of
the remaining 35, 20 died (57%mortality) of acute encephalitis
between 7 and 17 days postinfection. The 15 survivors were
checked weekly for development of signs of chronic demyeli-
nating disease. By day 168 postinfection, none had exhibited
clinical signs of disease, and the mice were sampled. The brains
and Purkinje cells in the cerebellum following direct inoculation of virus into this structure. The white matter is at the top, the granule cells form the densely packed
middle layer, and the lower layer is the molecular layer. Note pycnotic nuclei of infected cells (arrowheads). The Purkinje cells which should be present between the
granule and molecular layers have been destroyed. The large round vacuole between the two arrows may be the remains of a Purkinje cell. (C) Viral RNA-positive
motor neurons in the spinal cord. (D) Viral RNA in CA1 hippocampal pyramidal neurons. Extensive cell death with pycnosis, karyorhexis (arrowhead), and nuclear
debris is apparent. (E) Viral RNA-negative oligodendrocytes. (F) Viral RNA-positive oligodendrocyte. (G) Viral RNA-negative oligodendrocytes in area of heavy
infection. (H) Surviving viral RNA-negative oligodendrocytes in area of widespread destruction as evidenced by the absence of cells and presence of nuclear debris.
(I) Area of heavy infection with viral RNA-negative morphologically normal oligodendrocytes. Note the destruction of oligodendrocytes associated with viral RNA
(arrowheads). (J) Viral RNA-positive oligodendrocytes in area of widespread destruction. (K) Microglial response, as evidenced by cells of rod-shaped nuclei
(arrowhead), adjacent to viral RNA-positive cells. (L and M) Viral RNA-positive astrocytes with process (L) or with shrunken cytoplasm (arrowheads) (M). (O) Virus
RNA-positive cells in pyramidal layer of the hippocampus. (P) Viral infection of cerebral cortex, with widespread necrosis. (Q) GDVII RNA-positive cells in the
internal capsule. These are arranged in chains (arrowheads), typical of oligodendrocytes in white matter tracts. (R) Submeningeal polymorphonuclear cell infiltrate
(arrowhead).
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were divided sagittally, and the spinal cords were divided lon-
gitudinally. One half of each sample was processed for histo-
logical examination, and the other was processed for RNA
extraction. None (0 of 15) of the mice were virus positive by in
situ hybridization. Southern blot analysis of RT-PCR products
of RNA isolated from the CNS of these mice was also consis-
tently virus negative (Fig. 4). The sensitivity of the RT-PCR
was such that three molecules of GDVII genomic RNA diluted
in 100 ng of total brain RNA could be reverse transcribed and
PCR amplified and the product could be detected by Southern
blot hybridization. Taking into account that 1 mg of total CNS
RNA was used for RT-PCR and that on average 300 mg of
total RNA could be extracted from one brain, the limit of
detection of our assay was approximately 900 molecules of
GDVII RNA. It has been estimated that during chronic CNS
infection with DA virus, the majority of infected cells contain
100 to 500 copies of the viral genome (5). This would imply
that the limit of detection of our RT-PCR technique was ap-
proximately 9 to 2 persistently infected cells per brain.
DISCUSSION
Following i.c. inoculation of CBA and BALB/c mice, GDVII
replicated to high titers, producing an acute fatal encephalo-
myelitis from which all mice died by day 5. Viral RNA was
consistently detected in some areas and was consistently absent
in others. There was marked destruction of neurons and as-
trocytes but only rarely of oligodendrocytes and only in areas
of widespread infection. The pattern of infection was consis-
tent both with cell-to-cell spread, presumably as a result of
local release of infectious virus around cell bodies, and with the
spread of infection between distant areas connected by neuro-
nal pathways. Infection of cortical and basal ganglia neurons,
the early infection of spinal cord motor neurons, and the pres-
ence of viral RNA and proteins in neuronal processes are
consistent with the spread of GDVII along corticospinal tracts.
Hematogenous spread of TMEV has been proposed on the
basis of the observation that viral RNA can be observed in cells
associated with the vascular endothelium in the CNS (50). In
the present study, GDVII RNA was not detected in endothe-
lial or choroid plexus cells. Given the mechanism of GDVII
spread, it was notable that some neurons were consistently
negative for viral RNA, indicating an inability either to reach,
to infect, or to replicate within these cells. The most striking
examples were the dentate gyrus, which remained negative for
viral RNA, despite heavy infection of adjacent hippocampal
pyramidal neurons; the majority of thalamic nuclei, which were
virus negative despite infection of connecting cortical neurons;
and the cerebellum. In the case of the cerebellum, direct in-
oculation of virus demonstrated that the cells in this structure
are not refractory to infection and can replicate virus. The
consistent absence of virus-positive cells in this structure is
therefore likely to have resulted from a failure of virus to enter
or to traffic along cerebellar pathways before the mice died.
That infection of susceptible neuronal populations depends on
the route of inoculation has also been demonstrated in the
olfactory nuclei with the DA strain of TMEV (49). The con-
sistent absence of infection in specific areas such as the cere-
bellum which contain permissive cells would also argue against,
at least random, hematogenous spread of virus.
In previous studies, GDVII was detected exclusively in neu-
rons (27, 45). To investigate glial cell tropism, we developed a
highly sensitive double-labelling technique in which in situ
hybridization preceded immunocytochemistry. This was in con-
trast to most double-labelling studies in which this combination
was used in reverse order. This is the first study to demonstrate
GDVII infection of glial cells in vivo. GDVII RNA-positive
cells were predominantly neurons as determined by morphol-
ogy and location. Although fewer than virus-positive neurons,
astrocytes positive for viral RNA were also readily observed.
Infected oligodendrocytes were rare but nevertheless present.
The explanation for the low frequency of GDVII RNA-posi-
tive oligodendrocytes is not immediately apparent but could
depend on the access to, binding to, entry into, or replication
within these cells or a combination of these. That viral RNA
was detected in oligodendrocytes, even satellite oligodendro-
cytes, only in well-developed lesions could indicate that these
cells were infected only at late time points. Whereas this could
be the case in white matter tracts where inflammation, axonal
loss, or myelin damage could be a prerequisite for widespread
access of virus to these compact areas, it would seem less likely
for oligodendrocytes in the grey matter. Attachment or entry
of virus into oligodendrocytes could be less efficient than for
other cell types and could result, for example, from constitutive
low or only inducible expression of the viral receptor or inef-
ficient endocytosis. Finally, GDVII replication could be re-
stricted in oligodendrocytes as previously described for DA
virus (5 to 7). In this case, oligodendrocytes could even be
infected at the same time and with the same efficiency as other
cell types, but viral RNA would become detectable only as
transcripts slowly accumulated with time and virus-positive
cells would be observed only rarely and in late lesions. With
time, or perhaps in response to changes in, for example, the
external cytokine or physical environment, changes in the phys-
iology of the infected oligodendrocyte could lead to upregula-
tion of the viral receptor or enhanced virus replication. That
activation and/or differentiation states of cells can affect virus
replication has been shown for several systems including glial
cells (11–13, 19, 33, 37).
In our studies of BeAn tropism (43, 44) and those of others
with DA (1), viral RNA-positive oligodendrocytes are ob-
served only weeks after infection. In oligodendrocytes, GDVII
RNA can therefore be detected earlier than TO strain RNA.
Given the widespread nature of GDVII infection relative to
BeAn or DA infection (43, 44), this could result from the
increased chance of observing a rare event such as virus entry
into or unrestricted replication within an oligodendrocyte. Al-
ternatively, it could reflect more efficient entry or replication,
even restricted replication, of GDVII relative to BeAn.
Whether complete replication of virus in oligodendrocytes is
FIG. 4. Southern blot analysis of RT-PCR-amplified GDVII virus sequences
derived from brain and spinal cord pooled RNA. The RNA was extracted from
mice immunized and subsequently inoculated i.c. Lanes: 1, fX174 HaeIII digest
(Southern blot negative control); 2, RT-PCR reagents only, no template RNA;
3 to 8, RT-PCR of RNA from GDVII mice at 168 days postinoculation; 9 to 12,
RT-PCR of 10-fold serial dilutions from 1 to 1023 fg of purified GDVII RNA
diluted in 100 ng of uninfected total brain RNA; 13 to 16, 10-fold serial dilutions
of 1 to 1023 pg of B2 DNA (pGem3 harboring the 3.4-kb SalI-XbaI cDNA
restriction fragment of BeAn virus) (Southern blot-positive control). Bands were
visualized by using the enhanced chemiluminescence detection system with ex-
posure for 90 min. After 150 min, an additional band was visible in lane 11. All
experimental samples (3 to 8) were negative for viral RNA.
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destructive is not clear for either GDVII or TO strains. De-
struction of GDVII-infected oligodendrocytes was rare and
observed only in areas of widespread infection with destruction
of surrounding cells, an environment in which it is impossible
to determine the cause of the demise of the GDVII-positive
oligodendrocytes.
Our demonstration that GDVII can infect glial cells in vivo,
together with recent studies indicating that both virulent and
avirulent subgroups of TMEV encode genetic determinants of
demyelination (17), led us to investigate whether GDVII can
persist in the CNS. In CBA mice, susceptible to TO virus
persistence, immunization prior to infection with GDVII pro-
tected mice from lethal acute encephalomyelitis; however, by
168 days postinfection all survivors had cleared infection from
the CNS as detected by both in situ hybridization and RT-
PCR. These results are in agreement with recent studies using
chimeric GDVII and DA viruses which indicated that GDVII
does not contain genetic determinants of persistence and does
not cause chronic demyelinating disease (20, 24). Our results
clearly indicate that the inability of GDVII to persist does not
result from an inability to infect oligodendrocytes. However, as
with TO strains, infection of these cells relative to neurons and
astrocytes is either less efficient or restricted or both. In mice
resistant to TO virus persistence, CD81 T cells play a domi-
nant role in clearing virus from the CNS (2, 4, 15, 22, 23, 34,
40). The ability of mice susceptible to TO virus persistence to
clear GDVII could result from the ability of GDVII to elicit an
effective immune response, which could result, for example,
from a difference in T-cell epitopes, in particular those in VP1.
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